cbdMD (YCBD) Asset Writedowns and Impairment (2017 - 2023)
cbdMD (YCBD) posted Asset Writedowns and Impairment of $175499.0 for Q3 2023, up 100.37% sequentially from -$48.1 million in Q3 2022, and up 100.37% YoY from $87589.6 in Q3 2022.
cbdMD (YCBD) Asset Writedowns and Impairment (2017 - 2023) Analysis & Trends
cbdMD has reported Asset Writedowns and Impairment for 7 years, with the latest figure at $175499.0 in Q3 2023.
- Quarterly Asset Writedowns and Impairment rose 100.37% year-over-year to $175499.0 in Q3 2023, while the trailing twelve-month figure through Dec 2023 was $175499.0 (up 101.01% YoY) and the FY2025 annual result came in at $365979.0, down 60.28% from the prior year.
- Asset Writedowns and Impairment climbed to $175499.0 in Q3 2023 per YCBD's latest filing, from -$48.1 million in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $30.8 million in Q2 2022 and troughed at -$48.1 million in Q3 2022.
- A 5-year average of $34419.7 and a median of $118210.0 in 2020 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2020 and 2022: Asset Writedowns and Impairment surged 114.31% in 2020, then slumped 7270.15% in 2022.
- Over 5 years, Asset Writedowns and Impairment stood at $62011.0 in 2019, then soared by 90.63% to $118210.0 in 2020, then soared by 15282.19% to $18.2 million in 2021, then sank by 364.43% to -$48.1 million in 2022, then jumped by 100.37% to $175499.0 in 2023.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $175499.0, -$48.1 million, and $30.8 million for Q3 2023, Q3 2022, and Q2 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 175,499.00 |
| Sep 30, 2023 | 175,499.00 |
| Sep 30, 2022 | -48.08 Mn |
| Sep 30, 2022 | -48.08 Mn |
| Jun 30, 2022 | 30.78 Mn |
| Jun 30, 2022 | 30.78 Mn |
| Dec 31, 2021 | 18.18 Mn |
| Dec 31, 2021 | 18.18 Mn |
| Sep 30, 2021 | 670,580.00 |
| Sep 30, 2021 | 670,580.00 |
| Jun 30, 2020 | 118,210.00 |
| Jun 30, 2020 | 118,210.00 |
| Mar 31, 2020 | 53,151.00 |
| Mar 31, 2020 | 53,151.00 |
| Dec 31, 2019 | 62,011.00 |
| Dec 31, 2019 | 62,011.00 |
| Sep 30, 2019 | -2.11 Mn |
| Sep 30, 2019 | -2.11 Mn |
| Jun 30, 2019 | 906,717.00 |
| Jun 30, 2019 | 906,717.00 |